IDEAS home Printed from https://ideas.repec.org/a/spr/aphecp/v12y2014i3p239-253.html
   My bibliography  Save this article

Modelling the Economics of Type 2 Diabetes Mellitus Prevention: A Literature Review of Methods

Author

Listed:
  • P. Watson
  • L. Preston
  • H. Squires
  • J. Chilcott
  • A. Brennan

Abstract

Our objective was to review modelling methods for type 2 diabetes mellitus prevention cost-effectiveness studies. The review was conducted to inform the design of a policy analysis model capable of assisting resource allocation decisions across a spectrum of prevention strategies. We identified recent systematic reviews of economic evaluations in diabetes prevention and management of obesity. We extracted studies from two existing systematic reviews of economic evaluations for the prevention of diabetes. We extracted studies evaluating interventions in a non-diabetic population with type 2 diabetes as a modelled outcome, from two systematic reviews of obesity intervention economic evaluations. Databases were searched for studies published between 2008 and 2013. For each study, we reviewed details of the model type, structure, and methods for predicting diabetes and cardiovascular disease. Our review identified 46 articles and found variation in modelling approaches for cost-effectiveness evaluations for the prevention of type 2 diabetes. Investigation of the variables used to estimate the risk of type 2 diabetes suggested that impaired glucose regulation, and body mass index were used as the primary risk factors for type 2 diabetes. A minority of cost-effectiveness models for diabetes prevention accounted for the multivariate impacts of interventions on risk factors for type 2 diabetes. Twenty-eight cost-effectiveness models included cardiovascular events in addition to type 2 diabetes. Few cost-effectiveness models have flexibility to evaluate different intervention types. We conclude that to compare a range of prevention interventions it is necessary to incorporate multiple risk factors for diabetes, diabetes-related complications and obesity-related co-morbidity outcomes. Copyright Springer International Publishing Switzerland 2014

Suggested Citation

  • P. Watson & L. Preston & H. Squires & J. Chilcott & A. Brennan, 2014. "Modelling the Economics of Type 2 Diabetes Mellitus Prevention: A Literature Review of Methods," Applied Health Economics and Health Policy, Springer, vol. 12(3), pages 239-253, June.
    • Handle: RePEc:spr:aphecp:v:12:y:2014:i:3:p:239-253
    DOI: 10.1007/s40258-014-0091-z
    as

    Download full text from publisher

    File URL: http://hdl.handle.net/10.1007/s40258-014-0091-z
    Download Restriction: Access to full text is restricted to subscribers.
    File URL: https://libkey.io/10.1007/s40258-014-0091-z?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    References listed on IDEAS

    as
    1. Rob Anderson, 2010. "Systematic reviews of economic evaluations: utility or futility?," Health Economics, John Wiley & Sons, Ltd., vol. 19(3), pages 350-364, March.
    2. Thilo Schaufler & Malte Wolff, 2010. "Cost effectiveness of preventive screening programmes for type 2 diabetes mellitus in Germany," Applied Health Economics and Health Policy, Springer, vol. 8(3), pages 191-202, May.
    3. Feenstra, T.L. & van Baal, P.M. & Jacobs-van der Bruggen, M.A.M. & Hoogenveen, R.T. & Kommer, G.J. & Baan, C.A., 2011. "Targeted versus universal prevention. A resource allocation model to prioritize cardiovascular prevention," Other publications TiSEM da2bcf9c-cba4-4f97-86bf-a, Tilburg University, School of Economics and Management.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Sanjib Saha & Ulf-G Gerdtham & Pia Johansson, 2010. "Economic Evaluation of Lifestyle Interventions for Preventing Diabetes and Cardiovascular Diseases," IJERPH, MDPI, vol. 7(8), pages 1-46, August.
    2. Garattini, Livio & van de Vooren, Katelijne & Curto, Alessandro, 2015. "Cost-effectiveness of trastuzumab in metastatic breast cancer: Mainly a matter of price in the EU?," Health Policy, Elsevier, vol. 119(2), pages 212-216.
    3. Nadia Pillai & Mark Dusheiko & Bernard Burnand & Valérie Pittet, 2017. "A systematic review of cost-effectiveness studies comparing conventional, biological and surgical interventions for inflammatory bowel disease," PLOS ONE, Public Library of Science, vol. 12(10), pages 1-22, October.
    4. Tim Mathes & Maren Walgenbach & Sunya-Lee Antoine & Dawid Pieper & Michaela Eikermann, 2014. "Methods for Systematic Reviews of Health Economic Evaluations," Medical Decision Making, , vol. 34(7), pages 826-840, October.
    5. Edward Burn & Alexander D. Liddle & Thomas W. Hamilton & Sunil Pai & Hemant G. Pandit & David W. Murray & Rafael Pinedo-Villanueva, 2017. "Choosing Between Unicompartmental and Total Knee Replacement: What Can Economic Evaluations Tell Us? A Systematic Review," PharmacoEconomics - Open, Springer, vol. 1(4), pages 241-253, December.
    6. Katelijne Vooren & Alessandro Curto & Livio Garattini, 2015. "Pricing of forthcoming therapies for hepatitis C in Europe: beyond cost-effectiveness?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 16(4), pages 341-345, May.
    7. Lopert, Ruth & Ruiz, Francis & Chalkidou, Kalipso, 2013. "Applying rapid ‘de-facto’ HTA in resource-limited settings: Experience from Romania," Health Policy, Elsevier, vol. 112(3), pages 202-208.
    8. Elisabet Jacobsen & Dwayne Boyers & Alison Avenell, 2020. "Challenges of Systematic Reviews of Economic Evaluations: A Review of Recent Reviews and an Obesity Case Study," PharmacoEconomics, Springer, vol. 38(3), pages 259-267, March.
    9. Kalle Hirvonen, 2020. "This is US: Geography of evidence in top health economics journals," Health Economics, John Wiley & Sons, Ltd., vol. 29(10), pages 1316-1323, October.
    10. Claudine Bommer & Judith Lupatsch & Nicole Bürki & Matthias Schwenkglenks, 2022. "Cost–utility analysis of risk-reducing strategies to prevent breast and ovarian cancer in BRCA-mutation carriers in Switzerland," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 23(5), pages 807-821, July.
    11. Rajan Sharma & Yuanyuan Gu & Teresa Y. C. Ching & Vivienne Marnane & Bonny Parkinson, 2019. "Economic Evaluations of Childhood Hearing Loss Screening Programmes: A Systematic Review and Critique," Applied Health Economics and Health Policy, Springer, vol. 17(3), pages 331-357, June.
    12. Chen Min & Mi Xue & Fei Haotian & Li Jialian & Zhang Lingli, 2021. "An overview of the characteristics and quality assessment criteria in systematic review of pharmacoeconomics," PLOS ONE, Public Library of Science, vol. 16(2), pages 1-13, February.
    13. Mathilda Bongers & Veerle Coupé & Elise Jansma & Egbert Smit & Carin Groot, 2012. "Cost Effectiveness of Treatment with New Agents in Advanced Non-Small-Cell Lung Cancer," PharmacoEconomics, Springer, vol. 30(1), pages 17-34, January.
    14. Bonny Parkinson & Sallie-Anne Pearson & Rosalie Viney, 2014. "Economic evaluations of trastuzumab in HER2-positive metastatic breast cancer: a systematic review and critique," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 15(1), pages 93-112, January.
    15. Frank Pega & Nick Wilson, 2016. "A Systematic Review of Health Economic Analyses of Housing Improvement Interventions and Insecticide-Treated Bednets in the Home," PLOS ONE, Public Library of Science, vol. 11(6), pages 1-29, June.
    16. van Baal, Pieter & Morton, Alec & Severens, Johan L., 2018. "Health care input constraints and cost effectiveness analysis decision rules," Social Science & Medicine, Elsevier, vol. 200(C), pages 59-64.
    17. Anne Neumann & Lars Lindholm & Margareta Norberg & Olaf Schoffer & Stefanie J. Klug & Fredrik Norström, 2017. "The cost-effectiveness of interventions targeting lifestyle change for the prevention of diabetes in a Swedish primary care and community based prevention program," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 18(7), pages 905-919, September.
    18. Nora Döring & Susanne Mayer & Finn Rasmussen & Diana Sonntag, 2016. "Economic Evaluation of Obesity Prevention in Early Childhood: Methods, Limitations and Recommendations," IJERPH, MDPI, vol. 13(9), pages 1-11, September.
    19. Mandana Zanganeh & Peymane Adab & Bai Li & Emma Frew, 2019. "A Systematic Review of Methods, Study Quality, and Results of Economic Evaluation for Childhood and Adolescent Obesity Intervention," IJERPH, MDPI, vol. 16(3), pages 1-14, February.
    20. Vanessa Scarf & Christine Catling & Rosalie Viney & Caroline Homer, 2016. "Costing Alternative Birth Settings for Women at Low Risk of Complications: A Systematic Review," PLOS ONE, Public Library of Science, vol. 11(2), pages 1-17, February.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:spr:aphecp:v:12:y:2014:i:3:p:239-253. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.springer.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.